Trials / Completed
CompletedNCT03033602
Brief Treatment for Posttraumatic Stress Disorder
Brief Treatment for PTSD: Enhancing Retention and Engagement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 169 (actual)
- Sponsor
- Boston VA Research Institute, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.
Detailed description
The goal of this randomized clinical trial is to investigate if a brief, written intervention for posttraumatic stress disorder (PTSD), Written Exposure Therapy (WET), is non-inferior compared to an evidenced-based behavioral therapy, Cognitive Processing Therapy-Cognition only (CPT-C), in the treatment of PTSD in active duty military men and women with a diagnosis of PTSD who have deployed in support of a post-9/11. The primary study outcome is change in symptom severity as assessed by the Clinician Administered PTSD Scale for Diagnostic and Statistical Manual-5 edition (CAPS-5). Independent assessors evaluated participants using the CAPS-5 at baseline, 10-, 20-, and 30-week after the first treatment session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | written exposure therapy | five sessions of writing about traumatic experience. |
| BEHAVIORAL | CPT, cognitive only | 12 sessions of cognitive therapy related to traumatic experience. |
Timeline
- Start date
- 2015-07-20
- Primary completion
- 2020-12-15
- Completion
- 2021-03-31
- First posted
- 2017-01-27
- Last updated
- 2023-05-24
- Results posted
- 2023-05-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03033602. Inclusion in this directory is not an endorsement.